Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A person who is able to participate in the assessments required by the study.
- A person who is currently being followed up at the Movement Disorders specialist clinic within the Neurology Service at Hospital Sant Camil-Consorci Sanitari Alt Penedès i Garraf.
- A person who has the legal capacity to give informed consent.
- A person (or their legal representative) who has signed the informed consent form for the study.
- A person who meets the criteria for either Group 1 or Group 2 below:
Group 1 – Parkinson's disease tremor:
- A person with a confirmed, clinically established diagnosis of tremor caused by Parkinson's disease, based on Movement Disorders Society diagnostic criteria.
- A person whose tremor is associated with slowness of movement (bradykinesia), of any duration.
- A person whose Parkinson's disease tremor diagnosis (at an early to moderate stage, known as Hoehn and Yahr stages 1 to 2) has been confirmed by the neurologist responsible for their care.
Group 2 – Essential tremor:
- A person with a confirmed diagnosis of essential tremor, based on Movement Disorders Society criteria.
- A person with tremor that occurs when holding a position, combined with tremor during movement and/or at rest, who has been followed up in outpatient neurology clinics for at least 3 years without a change in their diagnosis.
- A person who does not have slowness of movement (bradykinesia).
Who may not be able to join:
- People currently taking antipsychotic or antidepressant medications.
- People with Parkinson's disease who also experience involuntary, uncontrolled movements (dyskinesias).
- People currently taking dopamine agonist medications or primidone.
- People whose tremor is so severe that it prevents them from producing a continuous line when writing or drawing, as judged by the study investigator.
- People with cognitive difficulties or mood-related conditions that would limit their ability to participate in study procedures.
- People already taking part in another clinical study whose requirements conflict with this study's procedures or visit schedule.
- People who have been diagnosed with any of the following:
- Alcohol use of a level that, in the investigator's judgement, affects handwriting or has caused nerve damage.
- Peripheral neuropathy (nerve damage) of any cause.
- Dystonia (a movement disorder involving involuntary muscle contractions).
- A previous stroke.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: José Luis Camacho, MD, Consorsi Sanitari Alt Penedes i Garraf
Phone: +34 938960025
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity; Specificity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.